Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
0.050 Biomarker disease BEFREE Screening of drugs to treat 8p11 myeloproliferative syndrome using patient-derived induced pluripotent stem cells with fusion gene CEP110-FGFR1. 25803811 2015
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
0.050 GeneticVariation disease BEFREE We report a rare case of t(8;9)(p11;q33) in a patient with 8p11 myeloproliferative syndrome (EMS) that was preceded by centrosomal protein 110kDa (CEP110; previously CEP1)/fibroblast growth factor receptor 1 (FGFR1) fusion transcript. 18295660 2008
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
0.050 Biomarker disease BEFREE A biphenotypic transformation of 8p11 myeloproliferative syndrome with CEP1/FGFR1 fusion gene. 16879608 2006
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
0.050 GeneticVariation disease BEFREE To date, four gene fusions associated with distinct translocations have been described in EMS: the t(8;13)(p11;q12), t(8;9)(p11;q33), t(6;8)(q27;p11) and t(8;22)(p11q22) fuse ZNF198, CEP110, FOP and BCR, respectively, to FGFR1. 11919391 2002
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
0.050 GeneticVariation disease BEFREE The 8p11 myeloproliferative syndrome (EMS) is associated with three translocations, t(8;13)(p11;q12), t(8;9)(p11;q33), and t(6;8)(q27;p11), that fuse unrelated genes (ZNF198, CEP110, and FOP, respectively) to the entire tyrosine kinase domain of FGFR1. 11550283 2001